drugset
drugset / Trial / NCT02618395

Bioavailability Study of SPARC001 in Healthy Adult Volunteers

NCT02618395 ↗

Phase 1 Completed 18 enrolled Sun Pharma Advanced Research Company Limited
RandomizedParallel-groupOpen-labelTreatment

Summary

Bioavailability study

Timeline

Start
2015-12-28
Primary completion
2016-01-25
Completion
2016-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule — —
Subject Hydrocodone Unknown — —
Subject SPARC001A Unknown — —
Subject SPARC001B Unknown — —

Indications

No indication recorded.